Cargando…

Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland

Detalles Bibliográficos
Autores principales:	Jayaprakash, Kiran, Glasmacher, Stella A., Pang, Bernard, Beswick, Emily, Mehta, Arpan R., Dakin, Rachel, Newton, Judith, Chandran, Siddharthan, Pal, Suvankar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Letter to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359150/ https://www.ncbi.nlm.nih.gov/pubmed/32447548 http://dx.doi.org/10.1007/s00415-020-09919-9

Ejemplares similares

A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis
por: Beswick, Emily, et al.
Publicado: (2020)

Prospective observational cohort study of factors influencing trial participation in people with motor neuron disease (FIT-participation-MND): a protocol
por: Beswick, Emily, et al.
Publicado: (2021)

The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in Scotland
por: Glasmacher, Stella A., et al.
Publicado: (2020)

Correction to: The immediate impact of the COVID‑19 pandemic on motor neuron disease services and mortality in Scotland
por: Glasmacher, Stella A., et al.
Publicado: (2020)

A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis
por: Beswick, Emily, et al.
Publicado: (2021)

Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis: a systematic review of in vitro studies
por: Ng Kee Kwong, Koy Chong, et al.
Publicado: (2020)

Targeting mitochondrial dysfunction in amyotrophic lateral sclerosis: a systematic review and meta-analysis
por: Mehta, Arpan R, et al.
Publicado: (2019)

A systematic review of digital technology to evaluate motor function and disease progression in motor neuron disease
por: Beswick, Emily, et al.
Publicado: (2022)

National audit of cognitive assessment in people with pwMND A national audit of cognitive assessment in people with motor neurone disease (pwMND) in Scotland
por: Stavrou, Maria, et al.
Publicado: (2020)

Riluzole and Edavarone: The Hope Against Amyotrophic Lateral Sclerosis
por: Rokade, Aditi V, et al.
Publicado: (2022)

Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective
por: Wong, Charis, et al.
Publicado: (2021)

Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study
por: Introna, Alessandro, et al.
Publicado: (2018)

Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis
por: Mazumder, Srestha, et al.
Publicado: (2022)

Administration of Riluzole Oral Suspension During the Different Stages of Amyotrophic Lateral Sclerosis
por: Povedano Panades, Mónica, et al.
Publicado: (2021)

Early initiation of riluzole may improve absolute survival in amyotrophic lateral sclerosis
por: Thakore, Nimish J., et al.
Publicado: (2022)

Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland
por: Leighton, Danielle J., et al.
Publicado: (2022)

Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes
por: Sala, Gessica, et al.
Publicado: (2019)

Dysphagia in Amyotrophic Lateral Sclerosis: Impact on Patient Behavior, Diet Adaptation, and Riluzole Management
por: Onesti, Emanuela, et al.
Publicado: (2017)

Assessment of Therapeutic Response of Edaravone and Riluzole Combination Therapy in Amyotrophic Lateral Sclerosis Patients
por: Samadhiya, Swapnil, et al.
Publicado: (2022)

Partial Block by Riluzole of Muscle Sodium Channels in Myotubes from Amyotrophic Lateral Sclerosis Patients
por: Deflorio, Cristina, et al.
Publicado: (2014)

Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis
por: Albertini, Claudia, et al.
Publicado: (2022)

A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
por: Dupuis, Luc, et al.
Publicado: (2012)

Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis
por: Dyer, Ann Margaret, et al.
Publicado: (2016)

Conjugal amyotrophic lateral sclerosis: a case report from Scotland
por: Fernandes, P. M., et al.
Publicado: (2017)

Improved detection of RNA foci in C9orf72 amyotrophic lateral sclerosis post-mortem tissue using BaseScope™ shows a lack of association with cognitive dysfunction
por: Mehta, Arpan R, et al.
Publicado: (2020)

Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis
por: Hinchcliffe, Michael, et al.
Publicado: (2017)

From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies
por: Mignani, Serge, et al.
Publicado: (2020)

In silico studies reveal structural deviations of mutant profilin-1 and interaction with riluzole and edaravone in amyotrophic lateral sclerosis
por: Sadr, Ahmad Shahir, et al.
Publicado: (2021)

Functional connectivity–based prediction of global cognition and motor function in riluzole-naive amyotrophic lateral sclerosis patients
por: Wei, Luqing, et al.
Publicado: (2022)

Repeated neurofilament light chain measurements did not capture Riluzole therapeutic effect in amyotrophic lateral sclerosis patients
por: Esselin, Florence, et al.
Publicado: (2022)

40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology?
por: Ng Kee Kwong, Koy Chong, et al.
Publicado: (2021)

Interstitial pneumonia and other adverse events in riluzole-administered amyotrophic lateral sclerosis patients: a retrospective observational study
por: Inoue-Shibui, Aya, et al.
Publicado: (2019)

The Effects of Riluzole on Cisplatin-induced Ototoxicity
por: Üstün Bezgin, Selin, et al.
Publicado: (2019)

Riluzole: Interstitial pneumonia: case report
Publicado: (2022)

Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease
por: Wong, Charis, et al.
Publicado: (2022)

Defining novel functions for cerebrospinal fluid in ALS pathophysiology
por: Ng Kee Kwong, Koy Chong, et al.
Publicado: (2020)

Spinal cord and brain concentrations of riluzole after oral and intrathecal administration: A potential new treatment route for amyotrophic lateral sclerosis
por: Keifer, Orion P., et al.
Publicado: (2023)

“Huoling Shengji granule” for amyotrophic lateral sclerosis: protocol for a multicenter, randomized, double-blind, riluzole parallel controlled clinical trial
por: Liu, Xiaolu, et al.
Publicado: (2023)

Riluzole Ameliorates Harmaline-induced Tremor in Rat
por: Shourmasti, Fatemeh Rahimi, et al.
Publicado: (2014)

Stability-indicating Method for the Estimation of Riluzole in Tablets
por: Neeha, T., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g6mei75gsu7rbs7is99hj3pmbo